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Clonal selection in the human Vd1 T cell repertoire
indicates gd TCR-dependent adaptive immune
surveillance
Martin S. Davey1,*, Carrie R. Willcox1,*, Stephen P. Joyce1, Kristin Ladell2, Sofya A. Kasatskaya3,4,5,
James E. McLaren2, Stuart Hunter1, Mahboob Salim1, Fiyaz Mohammed1, David A. Price2,
Dmitriy M. Chudakov3,4,5 & Benjamin E. Willcox1
gd Tcells are considered to be innate-like lymphocytes that respond rapidly to stress without
clonal selection and differentiation. Here we use next-generation sequencing to probe how
this paradigm relates to human Vd2neg T cells, implicated in responses to viral infection and
cancer. The prevalent Vd1 T cell receptor (TCR) repertoire is private and initially unfocused in
cord blood, typically becoming strongly focused on a few high-frequency clonotypes
by adulthood. Clonal expansions have differentiated from a naive to effector phenotype
associated with CD27 downregulation, retaining proliferative capacity and TCR sensitivity,
displaying increased cytotoxic markers and altered homing capabilities, and remaining
relatively stable over time. Contrastingly, Vd2þ T cells express semi-invariant TCRs, which
are present at birth and shared between individuals. Human Vd1þ T cells have therefore
evolved a distinct biology from the Vd2þ subset, involving a central, personalized role for the
gd TCR in directing a highly adaptive yet unconventional form of immune surveillance.
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gdT
cells have been preserved alongside ab T cells
and B cells over the lastB450 million years of
vertebrate evolution1, and are increasingly
recognized as having important roles in immune responses to
both microbial and non-microbial stress challenges2. Although gd
T cells recognize target cells in an MHC-independent fashion,
consistent with a lack of surface CD4/CD8ab co-receptor
expression, the key paradigms underpinning their distinct
immunobiology are unclear. Mouse studies have highlighted gd
T cell subsets bearing semi-invariant TCRs1,3–5, suggestive of an
innate-like biology and a limited range of self-ligands. In humans
the Vd2þ repertoire predominant in peripheral blood arguably
conforms to this paradigm. As for other unconventional
lymphocyte populations in humans such as natural killer T
(NKT) cells and mucosal-associated invariant T (MAIT) cells,
Vd2þ T cells feature a conserved chain pairing (in the case of
Vd2þ cells with Vg9), restricted CDR3 region diversity,
comprising motifs conserved between many individuals6, and is
generated early in gestation7. Most importantly, there is strong
evidence Vd2þ cells share a conserved biology, as they display
potent TCR-dependent reactivity to pyrophosphate antigens
generated by many species of bacteria/mycobacteria, with the
butyrophilin-like molecule BTN3A1 a central player in antigen
recognition8.
The extent to which these ideas apply to the human Vd2neg
repertoire, present in both blood and peripheral tissues, is
unclear. Previous studies have highlighted a diverse variable (V)
region usage for this subset, and a diverse range of ligands have
also been proposed for gd TCRs3, although to what extent they
represent physiological reactivities is uncertain. Moreover, some
studies have highlighted the potential for TCR-independent
effector functions9,10. Nevertheless, Vd2neg gd T cells are
implicated in immune responses to viral infection, particularly
cytomegalovirus (CMV)11,12, but also Epstein Barr virus13,14, and
can also recognize a broad range of cancer cells15. One possibility
is that within a seemingly diverse Vd2neg subset there exist
conserved innate-like populations; however, a distinct biology
underpinning Vd2neg gd T cell stress responses might
alternatively be involved. Characterizing the Vd2neg TCR
repertoire would enhance our understanding of this area.
Here, we use next-generation sequencing (NGS) approaches to
deﬁne the Vd2neg repertoire from human peripheral blood,
focusing on the predominant Vd1 subset. By comparing neonates
and healthy CMV-seropositive/CMV-seronegative adults, we
show that the Vd1 TCR repertoire is private, initially unfocused,
and subsequently shaped by TCR-dependent clonal selection,
concurrent with differentiation. These ﬁndings suggest that
a distinct mode of adaptive immune surveillance applies to the
Vd1 subset, and raise further questions regarding the nature of
the gd TCR-linked stress challenges driving evolution of these
responses in vivo.
Results
Vd2þ and Vd2neg T cell phenotype in human peripheral blood.
We ﬁrst characterized Vd2neg T cells in the peripheral blood of
healthy adult donors selected for subsequent repertoire analyses.
To account for possible effects of CMV status on phenotype12,16
we compared 10 CMV-seropositive and 10 CMV-seronegative
donors, selecting individuals of a similar age (18–30 years),
as previous studies have highlighted age-related changes in
the CMV-speciﬁc ab T-cell repertoire17,18 and the gd T-cell
repertoire in general19,20. In all individuals we detected Vd2þ
and Vd2neg gd T-cell populations (Fig. 1a), the latter dominated
by Vd1þ cells (Fig. 1a,b). Consistent with previous studies, we
observed a modestly increased proportion of Vd1þ cells in
CMVþ individuals (Fig. 1c). Furthermore, we noted
the presence of a Vg9/Vd1 chain pairing in all individuals
to varying degrees (Fig. 1d). Both Vd2neg T cells and the
Vd1þ subsets of gd T cells displayed a mixed CD27-/CD45RAþ
or CD27þ /CD45RAþ phenotype in most individuals
(Supplementary Fig. 1A,B), as previously described16.
In comparison, Vd2þ T cells were predominantly CD27þ
CD45RA (Supplementary Fig. 1A,B), consistent with previous
studies21.
The Vd1 TCR repertoire is focused on dominant clonotypes.
We used amplicon rescued multiplex (ARM)-PCR and
NGS methods to analyse the Vd2neg TCR repertoire in healthy
adults, focusing initially on the dominant Vd1 subset. We
achieved a mean sequencing depth of 346,371±27,993 reads with
an average of 2,742±432 unique CDR3 sequences for TCRd and
384,182±31,547 reads with an average of 1,261±170 unique
CDR3 sequences for TCRg (Supplementary Table 1), with no
correlation observed between sequencing depth and numbers of
unique CDR3 assigned (Supplementary Fig. 2A). Consistent with
successful puriﬁcation of Vd1 T cells, nearly all TCRd sequences
obtained used Vd1 (Fig. 2a); for TCRg, consistent with ﬂow
cytometry (Fig. 1a,d), Vg9 sequences were commonly prevalent
(Fig. 2a) and correlated with Vg9 antibody staining
(Supplementary Fig. 2B), although clonotypes using other func-
tional Vg gene segments were detected in all donors (Fig. 2a;
Supplementary Fig. 2C,D).
Strikingly, in most individuals (8/10 CMVþ and 5/10 CMVneg
adults), remarkably strong focusing of the Vd1þ response
was observed towards a small number of individual clonotypes
(Fig. 2b; Supplementary Fig. 2E). This was evident for both
TCRg and TCRd chains, and the majority of total error-corrected
reads could be accounted for by a small number of the
most prevalent clonotypes (r10) (Fig. 2b). TCRd D75 values
(the percentage of unique sequences required to account
for 75% of total reads) were o6% in this grouping
(mean 2.23±s.e.m. 0.53%), emphasising extreme skewing
(Fig. 2c). In addition, the Vg9/Vd1 populations consistently
present were often highly clonally focused. To address whether
this extreme clonotypic focusing was restricted to Vd1 sequences,
we developed a negative selection strategy enabling analysis
of the broader Vd2neg population (Supplementary Fig. 3A,B), in
four individuals. A more diverse range of Vd sequences
were observed in these analyses, including chieﬂy Vd3 and Vd8,
with evidence of moderate clonotypic focusing in some
individuals for Vd2neg, Vd1neg Vd chains (Supplementary
Fig. 3C), although these Vd regions were used in a small
percentage of clonotypes in these donors.
In contrast with this ‘focused adult’ subgroup, dramatically
less focused repertoires were observed in seven individuals
(TCRd D75 mean 14.95±s.e.m. 2.74%; in most cases the top
10 sequences representedo20% of the total error-corrected reads
detected) and used a varied set of Vg gene segments (Fig. 2d,e;
Supplementary Fig. 2D,F). These results establish that while not
universal, extreme clonotypic focusing is a common feature of the
Vd1 and Vd2neg gd TCR repertoire. Applying a TCRd D75
cut-off threshold of 6% (equivalent to the lowest quartile
TCRd D75 values), we deﬁned this minority of individuals
with higher D75 values as a ‘diverse adult’ subgroup (Fig. 2c).
While the average TCRd D75 values and Shannon-Weiner index
for CDR3d1 diversity highlighted a trend towards decreased
diversity (lower TCRd D75) in CMVþ versus CMVneg donors,
the difference was not signiﬁcant (Fig. 2f, left; Supplementary
Fig. 4). Notably the diverse adult donors were mostly (5/7)
CMV seronegative (Fig. 2c), and included the youngest members
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of the cohort. The difference in mean TCRd D75 values between
adult focused and adult diverse donors was B7-fold (2.23±0.53
versus 14.95±2.74 respectively, Po0.0002; Student’s t-test)
(Fig. 2f, right).
The cord blood Vd1 TCR repertoire is unfocused. To investi-
gate how the Vd1 repertoire differed in early life, we carried out
comparable TCR repertoire analyses on the Vd1þ subpopulation
of cord blood-puriﬁed gd T cells (Fig. 3a,b). Vd1þ cells dominate
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Figure 1 | Peripheral blood cd T-cell populations in donors analysed for cd TCR repertoires. (a) Major peripheral blood gd T-cell populations identiﬁed by
gd TCR chain speciﬁc antibodies. Flow cytometry plots are representative of 20 donors. (b) Frequency of gd T cells in CD3þ lymphocytes (left graph),
abundance of Vd2þ and Vd2neg T cells in the gd T cell compartment (Middle), and proportion of Vd1þ T cells in the Vd2neg gd T-cell sub-population
(Right). Graphs show the mean±s.e.m. from 20 donors. (c) Effect of donor CMV-seropositivity on CD8þ , Vd2þ and Vd1þ cell percentages in total
Tcells. Graphs show the mean±s.e.m. from 10 CMV-seropositive and 10 CMV-seronegative donors. (d) Prevalence of a Vg9 chain pairing in Vd1þ Tcells.
Graphs show the mean±s.e.m. and ﬂow cytometry plots are representative of 20 donors. Data analysed by student’s t-test, *P¼0.0228.
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the cord blood gd repertoire7, and expressed Vd1 paired with
diverse Vg regions (Fig. 3a). Cord blood TCRd1 and TCRg CDR3
sequences were extremely unfocused (TCRd D75 mean
14.06±s.e.m. 2.76%), in contrast to focused adult Vd1
repertoires (mean 2.23±s.e.m. 0.53%), but similar to unfocused
adult samples (mean 14.95±s.e.m. 2.74%) (Fig. 3c), and
comprised numerous low frequency clonotypes, the most
prevalent of which represented o1.30% and o2.17% of the
total unique CDR3s detected, for TCRg and TCRd respectively
(see cumulative frequency plots accounting for the 10 highest
prevalence clonotypes, Fig. 3d).
The Vd1 TCR repertoire is dominated by private clonotypes.
Detailed comparisons of CDR3 length (presented as spectratype
plots) within and between individuals indicated that in Vd1þ
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T cells, the mean CDR3d1 length was substantially greater
than CDR3g (mean 54 versus 33 nucleotides (nt; Fig. 4a), as
expected22). In addition, we detected a minority of exceedingly
long Vd1 CDR3s of 487 nt, some having up to 52 nontemplated
(N) nt added, which appear to be bona fide productive TCR
chains (Supplementary Fig. 5A,B). Frequency-normalized
analyses of CDR3 lengths in focused adults, diverse adults and
cord blood were essentially identical (Fig. 4a). However, non-
normalized comparisons of CDR3 length distributions, taking
into account the frequency of individual clonotypes, indicated
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that only unfocused adults’ repertoires had similar proﬁles to cord
blood. In contrast, individuals with focused Vd1 TCR repertoires
displayed highly skewed proﬁles (Fig. 4b).
Comparable analyses of the human Vd2þ repertoire in four
adults highlighted that while Vd1þ cells used various Vg and
Jg gene segments, Vd2þ cells almost exclusively used Vg9 paired
with JgP (Supplementary Fig. 6A,B), with CDR3g9 lengths of
11–18 amino acids (33–54 nt) (Fig. 4c), and 450% of CDR3s
composed of 14 amino acids in all donors. Moreover, analysis of
the ten most frequent TCRd and TCRg clonotypes in Vd2þ cells
from each donor revealed constrained lengths in both CDR3g9
and CDR3d2 (Fig. 4d). In contrast, in Vd1þ cells the CDR3g
and CDR3d lengths of the ten most frequent clonotypes,
typically accounting for 450% of the repertoire, were extremely
diverse both within and between individuals (Fig. 4d, Suppleme-
ntary Fig. 6C). Consistent with this, multidimensional clustering
analysis conﬁrmed the TCRg CDR3 length distributions of Vd2þ
T cells were similar across different donors, whereas those of the
Vd1 compartment were highly individual (Supplementary
Fig. 6D).
Importantly, comparisons of the ten most prevalent TCRg and
TCRd1 clonotypes from each donor revealed they were private
sequences, absent in any other individuals either at a nucleotide
or amino acid level (Supplementary Tables 2–5; Fig. 4e).
Consistent with this, they frequently involved extremely complex
CDR3 regions, comprising numerous N/P nucleotide additions
(1–11 nt for TCRg; 5–28 nt for TCRd) in addition to D and
J region nucleotides (Supplementary Tables 2–3), indicating rare
recombination events. This was particularly pronounced for
the predominant Vd1 chains in each donor, which utilized
1–2 Dd regions and contained a mean of 16 N/P nucleotides.
Indeed, after error correction, nearly all CDR3d and CDR3g
sequences were found to be private. The very few TCRg and
TCRd clonotypes observed in 41 individual generally resulted
from relatively simple recombination events with little N nt
addition, and were low in frequency. Comparison of
Vd1 repertoire data with age and sex matched TCRb repertoire
data revealed that Vd1 as a repertoire was even more private than
TCRb (Fig. 4f). Therefore, the Vd1 TCR repertoire was
overwhelmingly private, with different TCR clonotypes present
in each individual, and these observations also extended to
non-Vd1 sequences in our Vd2neg gd T cell analyses, suggesting it
may be a generic property of the Vd2neg TCR repertoire.
In contrast, several Vd2 subset-derived CDR3g protein
sequences were shared between all four samples at a relatively
high frequency (Fig. 4g; Supplementary Fig. 7A,B). These
involved recombination of Vg9 and JgP segments with limited
N/P nucleotide addition (generallyo3 nt) indicating their origin
from convergent recombination23. Vg9 sequences in Vd2þ cells
were constrained in length (Fig. 4c,d) and were more public than
TCRd, TCRb chains and TCRg in Vd1þ cells (Fig. 4f), and often
contained a typical 14 amino acid sequence motif (Supplementary
Fig. 7C)6,7,24. Although Vd2 sequences were relatively private
compared with TCRg (Fig. 4f,g), more CDR3d2 sequences
were shared between donors than CDR3d1 sequences (Fig. 4f).
As previously noted, CDR3d2 often contained a hydrophobic L or
V residue at position 6 (Supplementary Fig. 7D)24. Therefore,
in stark contrast to Vd1þ T cells, but analogous to iNKT25
and MAIT26 populations, the Vd2Vg9 population expresses
a semi-invariant TCR.
Vd1 clonal expansions are long-lived and differentiated. To
conﬁrm that the prevalent clonotypes we detected genuinely
reﬂected differential lymphocyte expansion rather than
disproportionate expression levels of speciﬁc TCR transcripts, we
single cell sorted the Vg9Vd1 T cell population, which frequently
featured highly dominant clonotypes (Fig. 2), from six healthy
adult donors, and used RT-PCR to identify Vg9Vd1 TCR pairs
(Fig. 5a). In each case, the dominant Vg9 and Vd1 TCR chain
evident from NGS analyses was identiﬁed in 450% of sequences
(Fig. 5b), conﬁrming that the prevalent clonotypes detected
in the NGS analyses truly reﬂected clonal dominance at the
cellular level.
To assess whether the dominant Vd1 expansions are stably
maintained over time, we compared our ARM-based repertoire
analyses with an analogous, RNA-based RACE TCR repertoire
analysis, conducted previously on 5 individuals from our cohort
(2 CMV-seronegative, 3 CMV-seropositive). In 5/5 donors
analysed, the most frequent clonotypes from RACE analysis were
detected in subsequent ARM analyses, conducted between 12–18
months later (Fig. 5c). Also, in most donors, the hierarchy of
prevalent clonotypes was broadly conserved in both analyses
(Fig. 5c). Therefore clonotypic expansions prevalent in the Vd1
T-cell repertoire can be highly stable over time.
Next, we assessed how Vd1þ T-cell differentiation status
correlated with the extent of clonotypic focusing. We sorted
sub-populations of Vd1þ cells based on expression of CD27 and
CD45RA, markers that have been used to identify naı¨ve and
memory subsets in CD8 cells27 and gd T cells16. Strikingly we
observed the vast majority of clonal populations resided in
CD27lo/neg- CD45RAþ populations (gates C and D), whereas
clonotypes found in CD27hi populations (gates A and B) were
strikingly diverse (Fig. 5d). Notably, when applying a CD27hi
and CD27lo/neg gating strategy to individuals with focused
Vd1 TCR repertoires, they displayed a dominant CD27lo/neg
CD45RAþ phenotype but also retained a minor CD27hi
population, whereas Vd1 T cells of both cord blood, and Vd1
diverse adults, were predominantly CD27hi (Fig. 5e).
Furthermore, focused donors had elevated percentages of
Figure 4 | CDR3 length and diversity within the Vd1 and Vd2 TCR. (a) Comparison of the mean±s.e.m. from frequency-normalized CDR3d and CDR3g
length spectratyping for Vd1þ T cells in CMVneg (n¼ 5), CMVþ (n¼ 8), adult diverse (n¼ 7) and cord blood (n¼ 5) donors. (b) Comparison of non-
normalized CDR3d length spectratyping for Vd1þ T cells from 3 representative individuals from CMV-seronegative (representative of n¼ 5), CMV-
seropositive (representative of n¼ 8), adult diverse (representative of n¼ 7) and cord blood (representative of n¼ 5) donor groupings. (c) Non-normalized
length spectratyping for CDR3d and CDR3g in adult Vd2þ T cells (n¼4). (d) Length distribution and mean (red line) within the top 10 most prevalent
clonotypes in CDR3d (left two panels) and CDR3g (right two panels) of Vd1þ T cells (5 donors shown, representative of 20) and Vd2þ T cells (from 4
donors). (e) Publicity in the 10 most prevalent clonotypes for each donor’s Vd1þ TCR repertoire compared against all other donors (both aa and nt
sequences compared). (f) Comparison of relative publicity in TCR repertoires. Overlap of individual TCR repertoires in TCRd1 (n¼ 15), TCRd2 (n¼4), TCRb
(n¼ 15, ref PMID: 27183615), TCRg of Vd1þ cells, TCRg of Vd2þ cells and TCRa (n¼ 3). Each dot shows relative similarity of repertoires for a pair of
unrelated donors in terms of the shared TCR variants with identical amino acid CDR3 sequence, and V and J segments used. Overlap was estimated either
as a number of clonotypes shared between the sets of top-1,000 largest clonotypes of each repertoire (left), or as a sum of clonotype frequencies shared
between the total repertoires (F2 metrics of VDJTools software, right). (g) Publicity in the 10 most prevalent clonotypes for each donor’s Vd2þ TCR
repertoire compared against all other donors (both aa and nt sequences compared). Mean overlap of sequences between each group was analysed by
Kruskal–Wallis ANOVA with Dunn’s post-test comparisons *Po0.003.
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Figure 5 | Vd1 clonal expansion and differentiation is associated with decreased CD27 expression. (a) PCR detection of Vg9 and Vd1 TCR chains
in single cell sorted Vg9Vd1 T cells. n¼6. (b) Frequency of each individual’s dominant clone among single cell sorted Vg9Vd1 T cells. (c) Sequential
TCR repertoire analyses in three individuals using RACE-PCR (left panel, ﬁrst time point), and deep-sequencing ARM-PCR (middle panel, second time
point, 12–18 months later). Clonotypic sequences are coloured consistently. The right panel depicts the frequency of the top clone within the repertoire over
the two time points. (d) Relationship between CD27 and CD45RA expression and clonality by single cell PCR analysis of CDR3d. Each colour represents
an individual CDR3d, with clonal sequences labelled below each chart (from 24 single cells per-population). Data are from one donor, representative of 3.
(e) Vd1þ T cells were segregated into CD27hi and CD27lo/neg, informed by TCR sequence clonality in d, and this FACS-gating strategy was applied to
focused adults (top row, n¼ 13), unfocused diverse adults (second row, n¼ 7), and cord blood (third row, n¼4). Flow cytometry data is shown for
representative donors, with all donors shown with mean±s.e.m. (right column). (f) Comparison of Vd1þ CD27lo/neg cells from all adult and cord blood
donors (left panel), correlation with CDR3d D75 (middle) and Chao1 TCRd1 diversity metric, normalized to 50,000 randomly chosen CDR3 sequencing
reads, (right) for each donor. (g) TCRd repertoire analysis of sorted CD27hi and CD27lo/neg Vd1þ T cells, showing Tree maps (top row), accumulated
frequency graphs of the top 10 clonotypes (bottom row) and CDR3d D75 values (right column). (h) Comparison of CD27, CCR7, CD62L, CD28 and IL-7Ra
expression within CD8þ T EMRA, CD8
þ T naı¨ve, Vd1
þ CD27hi and Vd1þ CD27lo/neg T cells. Histograms from one representative donor and graphs show
mean±s.e.m. from 14 different donors. Data analysed by Kruskal–Wallis ANOVA with Dunn’s post-test comparisons, *Po0.05, **Po0.01 and
****Po0.0001.
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Vd1þ /CD27lo/neg cells compared with diverse and cord
blood donors (Fig. 5f, left). Moreover, the percentage of
CD27lo/neg cells each donor displayed inversely correlated
with the TCRd D75 and Chao 1 indices of Vd1 diversity
(Fig. 5f, right panels). These correlations suggested that Vd1 TCR
repertoire focusing was accompanied by transition of Vd1þ
T cells from a CD27hi CD45RAþ to a CD27lo/neg CD45RAþ
phenotype. To test this directly, we sorted Vd1þ CD27hi
versus CD27lo/neg populations from two focused adult donors
and performed NGS TCR repertoire analysis. This unequivocally
conﬁrmed that the Vd1þ /CD27hi population displayed
a diverse TCRgd repertoire, generating TCRd repertoires
and TCRd D75 values similar to cord blood and diverse adult
donors, whereas the Vd1þ /CD27lo/neg population was comprised
of even more pronounced dominant TCR clonotypes (Fig. 5g),
compared with each donor’s original TCRd repertoire proﬁle
(Fig. 2b). Inter-individual comparisons revealed the majority of
Vd1þCD27hi T cells expressed other markers typical of naı¨ve
CD8 T cell populations including IL-7Ra, CD28, and CCR7 and
CD62L, while Vd1þ /CD27lo/neg cells had downregulated surface
expression of these markers similarly to memory CD8
compartments (Fig. 5h) (reviewed in Akbar and Fletcher,
2005)17. Although CD45RA and CD27 have been used before
to assign gd memory compartments16,21, our CD27hi versus
CD27lo/neg gating strategy represents a new approach to
immunophenotyping Vd1 populations, which more closely
aligns naı¨ve/effector marker expression to Vd1 TCR diversity/
clonality.
Vd1þCD27lo/neg clones respond to IL-15 and TCR stimulation.
Comparisons of the functional responsiveness of total Vd1 T-cell
subsets indicated robust CD3/CD28-dependent activation equiva-
lent to CD8þ T cells and Vd2þ gd T cells (Fig. 6a). However,
Vd1þ CD27lo/neg T cells displayed a markedly enhanced respon-
siveness to both CD3/CD28 and IL-15 relative to CD27hi Vd1 T
cells after short-term stimulation (Fig. 6b). Importantly, and unlike
Vd2þ T cells, Vd1þ T cells were largely unresponsive to the
innate T cell trophic IL-18 or IL-12 cytokines (Fig. 6a,b).
In keeping with their high IL-7Ra expression (Fig. 5g), CD27hi
Vd1 subsets proliferated preferentially in response to IL-7 stimu-
lation relative to CD27lo/neg Vd1 populations, whereas the latter
displayed more pronounced IL-15-induced proliferation (Fig. 6c).
Moreover, single cell PCR conﬁrmed that cells that proliferated
(that is, became CFSElo) in 7-day IL-7 cultures predominantly
expressed diverse TCRs, irrespective of whether Vd1 T cells
were analysed on bulk or segregated into Vd1 CD27hi and Vd1
CD27lo/neg subsets, whereas expanded clonotypes proliferated
preferentially in response to IL-15 (Fig. 6d). In addition, both
CD27hi and CD27lo/neg populations responded to CD3/CD28
(Fig. 6c) and, separately, to anti-gd TCR antibody stimulation in
7-day cultures. CD27lo/neg populations in general exhibited some-
what enhanced proliferative responses to anti-gd TCR antibody
(Fig 6c; P¼ 0.0458) relative to CD27hi cells. This suggests that
although expanded Vd1 clones have a CD45RAþ /CD27lo/neg
phenotype normally associated with CD8 TEMRA cells, they are
capable of proliferating in response to signals through the TCR
and IL-15.
Vd1þCD27lo/neg clones express cytotoxic markers and CX3CR1.
A hallmark of effector T cell subsets is the acquisition of intra-
cellular cytotoxic granules, therefore we assessed intracellular
cytotoxic marker expression in both CD27hi and CD27lo/neg Vd1
T-cell subsets (Fig. 7a). CD27hi Vd1 T cells largely lacked
Granzyme A or B and perforin expression, whereas these markers
were markedly upregulated in CD27lo/neg Vd1 T cells, again
matching levels in naı¨ve and effector memory CD8þ T-cell
subsets, respectively. Next, we assessed the proportion of Vd1
T cells that expressed Granzyme A/B and found this signiﬁcantly
correlated with the extent of focusing (TCRd D75, P¼ 0.0071).
CX3CR1 (fractalkine receptor) was preferentially expressed in
CD27lo/neg versus CD27hi naive-like Vd1þ T cells (Fig. 7b) and
CX3CR1 expression in Vd1
þ T cells exclusively marked
out Granzyme Bþ cells whereas CX3CR1
neg Vd1þ T cells pre-
dominantly expressed IL-7Ra (Fig. 7b). We then assessed
TCR usage on the single cell level and in each donor, CX3CR1þ
cells within the Vd1þ T-cell population were composed exclu-
sively of clonotypically expanded sequences, with each sequence
identity matching those detected in deep sequencing analysis,
whereas CX3CR1neg cells were predominantly composed of
multiple diverse TCRs (Fig. 7c). Together, these data indicate that
clonal expansion is inextricably linked to changes in homing
receptor, CD27 and cytolytic effector expression.
Discussion
gd T cells have been highlighted as a key cellular exemplar of
lymphoid stress surveillance, which invokes unconventional
lymphocytes that can quickly initiate responses to stress
challenges without the obligatory delay associated with clonal
expansion and differentiation28, a paradigm thought to apply to
some murine gd TCR subsets29. Although Vd2þ cells increase in
number upon microbial challenge30, they arguably ﬁt this
paradigm7. However, how it applies to human Vd2neg T cells
has to date remained unclear.
Our ﬁndings expose several features of Vd1 T cells, which
comprise the dominant proportion of Vd2neg T cells, that
differ fundamentally from this paradigm. Instead of being
pre-expanded, in most adults a small number of speciﬁc
clonotypes emerge from an initially unfocused neonatal
Vd1 T-cell repertoire, undergo pronounced clonal expansion,
and ultimately dominate the Vd1 gd T-cell compartment.
Notably, such clonotypic expansions were relatively stable over
time, and their occurrence was not an inevitable consequence
of a maturing gd T-cell compartment, as a sizeable minority of
adults had largely unfocused repertoires. CDR3 sequences of
dominant clonotypes were extremely complex, suggesting
heavy selection of initially low frequency clonotypes resulting
from single, unlikely recombination events. Consistent with this,
Vd1 TCR sequences observed were, overwhelmingly, unique to
each individual, indicating the Vd2neg repertoire, including
dominantly expanded clonotypes, is essentially private.
Conversely, analyses highlighted Vg9/Vd2 cells shared sequences
in TCRg and (to a lesser extent) TCRd, conﬁrming this subset
featured a semi-invariant TCR.
Importantly Vd1 clonal expansion was accompanied by
phenotypic differentiation and a distinct functional biology.
Unfocused adult TCR repertoires were associated with apparently
naı¨ve Vd1 populations characterized by a CD27hiCCR7þCD28þ
IL-7RaþCD62Lþ phenotype evident in all individuals but
predominant in the diverse adult subgroup; moreover, cord
blood Vd1 cells largely conformed to this phenotype. Conversely,
clonally expanded populations were analogous to CD8 T effectors
in displaying a CD27lo/negCCR7negCD62LloCD28negIL-7Raneg
phenotype, and similarly were marked out by CX3CR1 expres-
sion. Relative to CD27hi Vd1þ cells, CD27lo/neg Vd1 subsets
displayed more rapid activation and proliferation in response
to CD3/TCR stimulation, upregulation of multiple cytotoxic
markers equivalent to CD8 EMRA subsets, differential cytokine
responsiveness (enhanced to IL-15 and a lack of response to
IL-7), and differential homing receptor expression, consistent
with a functional effector status. In contrast, CD27hi Vd1þ
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cells were single cell sorted and CDR3d sequenced by PCR, prevalent clonotypes detected by previous deep sequencing are coloured and diverse individual
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T cells were responsive to IL-7, expressed secondary lymphoid
homing receptors, displayed relatively slow proliferation
kinetics after TCR stimulation, and largely lacked expression of
perforin/granzymes, consistent with a functionally naı¨ve status.
Collectively, these ﬁndings reveal a fundamentally adaptive
biology for Vd1 T cells, and suggest the gd TCR has a central
role in driving this biology. While they do not formally exclude
the possibility that stochastic processes could explain the
expansions we observe, they strongly support a model involving
clonal selection of naı¨ve Vd1 T cells that express functionally
useful TCRs enabling responses to microbial/non-microbial stress
challenges encountered, accompanied by differentiation to an
effector phenotype. They argue against the idea that Vd1
clonotypic focusing merely represents an immunological imprint
of past stress challenges, and instead are more suggestive of
long-lived, highly speciﬁc, functional gd T-cell memory that
a
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enables augmented responses to recurrent stress challenges, akin
to classical immunological memory, although importantly, not
MHC-restricted.
The model outlined above shares several key tenets with
classical adaptive immunity, but differs critically in being
MHC-unrestricted, and represents an unconventional mode of
adaptive immune surveillance. Although one limitation of our
study is that it focuses predominantly on Vd1 T cells, our
repertoire data highlight that Vd3 and Vd8 populations exhibited
a degree of clonotypic focusing and were equivalently private to
Vd1 repertoires, suggesting the biology we observe for Vd1 T cells
could also apply to other human Vd2neg T cells. However, in
several key respects this model does not apply to Vg9/Vd2 T cells.
In contrast to Vd1 populations our Vg9/Vd2 TCR repertoire
data conﬁrm highly restricted CDR3 lengths, including prevalent
Vg9 sequences of limited complexity that were common to
multiple individuals. Consistent with these data, Dimova et al.7
detected prevalent Vg9 sequences that were present at birth in
multiple individuals, irrespective of pathogen exposure. These
observations are consistent with a semi-invariant, innate-like
biology for the Vg9/Vd2 subset that is in keeping with their
polyclonal activation by pyrophosphate antigens. In contrast,
a conﬂuence of features we observe in Vd1 T cells, which include
profound clonotypic expansions of often highly complex
TCRs from an initially completely unfocused, private repertoire,
and concomitant phenotypic differentiation involving loss of
secondary lymphoid homing markers and upregulation of
effector molecules, point to a very different adaptive biology.
This model raises a number of questions, including regarding
Vd1–positive T-cell homing. The majority of naı¨ve CD27hi Vd1
subsets expressed both CCR7 and CD62L, suggesting they may
access secondary or alternatively tertiary lymphoid organs, and
may become primed there before differentiating to CD27lo/neg
effectors, which are CCR7neg CD62Llo, but also display CX3CR1
upregulation, which may affect peripheral or endothelial homing.
How this transition occurs is unclear, however conceivably
dendritic cells, which prime ab T-cell responses, may also prime
MHC-independent Vd1 responses. How our results relate to
Vd2neg development in solid tissues, where they represent the
dominant gd T-cell subset, is unclear, but could potentially
involve central or local priming events. Also, the kinetics of
Vd2neg T-cell responses merit further investigation, but might
parallel those of conventional ab T-cell adaptive responses.
Although the stress challenges underlying Vd2neg clonotypic
focusing are uncertain, one obvious possibility is infection.
Although Vd2neg T-cell responses have been strongly linked with
CMV infection11,15 they are not limited to this setting, since we
found CMV-seronegative individuals also exhibited extreme
clonotypic focusing. Further studies assessing in parallel Vd2neg
TCR repertoire focusing and microbial exposure, including
during stress stimuli such as acute CMV infection, will shed
light on how Vd2neg adaptive immune surveillance operates
during relevant infectious challenges. Our model would predict
a small number of previously low frequency clonotypes may
become heavily expanded during/after such challenges. Moreover,
dissecting the reasons why some adults retain largely unfocused,
naive Vd1 repertoires is important. Although differential
pathogen exposure may be one factor, ‘holes’ might conceivably
exist in the Vd1 TCR repertoires of certain individuals, resulting
in an inability to respond to a speciﬁc pathogen. In addition,
while we introduced a binary delineation of our cohort into
‘focused’ and ‘diverse’ individuals, both CD27hi and CD27lo/neg
Vd1 subpopulations were present in all individuals, highlighting
both the universal nature of the adaptive biology we observe and
also the fact that in reality there is likely to be a continuous
spectrum of diversity. Understanding when clonotypic focusing
occurs in life is clearly important, including in neonates, when
conventional adaptive immunity is less potent and gd T-cell
responses may play an important role31,32. Further studies are
required to more comprehrensively explore Vd1 repertoire
focusing throughout life, and how this links with pathogen
exposure.
How Vd2neg adaptive immune surveillance relates to gd TCR
ligand recognition merits consideration. As the focusing we
observe is highly CDR3-speciﬁc, even within the same chain
pairing combination, we hypothesize it results from TCR
ligand-dependent selection. The identity of ligands for such
speciﬁcities is largely unclear (see below), but might include
self-encoded and/or foreign proteins3,33–37. Furthermore,
although the private TCR repertoires we observe may reﬂect
reactivities restricted to each individual, they do not formally
exclude the possibility of degenerate recognition of conserved
ligands by diverse TCRs.
Studies on Vd2neg T cells have highlighted a diverse and
somewhat confusing range of TCR ligands. While these ligands
highlight the broad recognition capabilities of the Vd2neg gd TCR,
their physiological importance is less clear. For future studies,
our model strongly suggests that natural in vivo expansion
and phenotypic differentiation may be important considerations
in assessing the biological relevance of proposed gd TCR ligands
to adaptive immune surveillance by Vd2neg T cells, and for
prioritising clonotypes for ligand identiﬁcation. From this
perspective, while unequivocal binding and/or structural
data have been determined for phycoerythrin (PE) - and CD1d-
reactive Vd2neg TCRs33,35,37, both PE and CD1d reagents
published to date stain a small percentage (o0.1%) of Vd1
T cells in peripheral blood in the absence of in vitro expansion,
and the naı¨ve/effector phenotype of such cells is unclear. While
such cells clearly do not represent dominantly expanded blood
clonotypes, reactive populations could be preferentially localized
to solid tissues or be lipid-speciﬁc. By analogy, notably CD1d-
restricted iNKTs comprise a minor component of ab T cells in
peripheral blood but are highly prevalent in liver38. Furthermore,
conceivably expanded clonotypes could recognize particular
CD1d-presented lipids. Further studies are required to resolve
these questions.
In this context, gd TCR speciﬁcities present on Vd2neg T cells
naturally expanded during infection, which include the LES36 and
POS4 (ref. 39) TCRs, may be particularly relevant. The LES TCR,
which directly binds Endothelial Protein C Receptor36,
conceivably represents a molecular exemplar of Vd2neg adaptive
immune surveillance. Naturally expanded during acute CMV
infection toB20% of total T cells, the LES clone was CD28neg
CD45ROneg, suggestive of an effector phenotype40. Also, the
LES TCR utilizes a highly complex TCRd rearrangement
(incorporating 14 N/P additions) and a simpler TCRg chain,
typical of many of the Vd2neg dominant clonotypes we observed
in this study. However LES TCRd exact sequences were not
observed in any individual from our cohort, and at least the
CDR3 region of the LES TCRg chain has been highlighted as
important for LES/EPCR ligand binding36. These observations
not only indicate the LES TCR was private to the individual in
which it originated, but, raise the possibility that reactivity to
EPCR might also be private, consistent with failure of previous
attempts to identify reactivity to EPCR in other individuals36.
The Vg8Vd1 POS4 TCR, also derived from a clonotype expanded
in acute foetal CMV infection39, would superﬁcially appear to
conﬂict with this study, as it was observed in multiple individuals.
Tellingly, POS4 is exceptional in comprising CDR3g and CDR3d
both resulting from recombination of germline-encoded segments
without any N/P nt addition (Supplementary Tables 2 and 3). We
suggest this TCR is preferentially generated in gestation before
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TdT is expressed at 20 weeks41, and that its expansion during acute
infection may reﬂect recognition of an important CMV-associated
(although not necessarily CMV-encoded) ligand. Therefore, while
our data stress the overwhelmingly private nature of the Vd2neg TCR
repertoire, the POS4 TCR clonotype, because of its generation and
expansion in utero, may be the ‘exception that proves the rule’,
relative to most adult peripheral TCR sequences.
Pre-expanded, semi-invariant T cells such as MAIT, iNKT and
some gd T-cell subsets, as well as NK cells, may permit rapid
responses to stress challenges such as pathogen infection, before
conventional adaptive immunity has time to develop28. What
advantage would a parallel Vd2neg adaptive immune surveillance
system provide, involving clonal selection of private TCR clono-
types from a diverse repertoire? Possibilities include the potential
for ampliﬁcation of the stress response, and immunological
memory to recurrent stress stimuli, both justifying further
investigation. Secondly, the system may permit diverse routes to
recognition of ‘altered self’. One potential paradigm was
suggested by LES reactivity to EPCR, which enabled functional
reactivity to CMV-infected endothelial cells (a key target for
CMV infection in vivo) via a TCR-extrinsic, CMV-induced
‘multimolecular stress signature’36. However additional
paradigms will no doubt emerge from identiﬁcation of further
ligands for clonotypes naturally expanded in vivo. Finally, another
important consideration is the protection from pathogen immune
escape mechanisms provided by Vd2neg adaptive immune
surveillance versus stress sensing by alternative routes such as
innate immune subsets, NK cells, and semi-invariant T cells.
Generally, these alternative cell types rely on conserved germline-
encoded receptors/ligands such as PRRs that sense PAMPs/
DAMPs, NKG2D that recognizes MHC-like stress antigens, and
MHC-like molecules such as MR1/CD1. Notably, there is strong
evidence for pathogen escape from both PRRs42 and NKG2D43.
Morever, CD1 molecules recognized by NKT cells, like class I
MHC molecules themselves, are targeted by various viral
proteins44, and MAIT cells are decreased in HIV45. In contrast,
the evolution of a parallel adaptive immune surveillance system,
involving a radically different biology centred on clonal
ampliﬁcation from within a diverse, private Vd2neg antigen
receptor repertoire, and potentially exploiting diverse ligands
private to each individual, may provide a much greater challenge
for pathogens to evade.
Vd2neg T cells are strongly implicated in pathogen-speciﬁc11
and anti-tumour immunity46, and are the subject of increasing
immunotherapeutic interest. Three aspects of the adaptive
biology we outline here have translational relevance. Firstly,
major differences in the ability of speciﬁc, private Vd2neg
gd TCRs to mediate physiologically relevant antigen recognition
events would open the possibility of identifying and exploiting
optimal Vd2neg TCR clonotypes (for example, via T-cell
engineering), to enhance pathogen/cancer-speciﬁc immunity.
Secondly, the longevity of dominant clonotypes suggests
interaction of vaccination approaches with Vd2neg immune
surveillance merits further investigation, and might be
manipulable to enhance vaccine protection. Finally, a greater
understanding of the relationship between different Vd2neg
TCR ligands, their mode of recognition, tissue expression and
regulation/dysregulation, will undoubtedly provide novel
therapeutic avenues and insights.
Note added in proof: Consistent with the suggestion that viral
infection may be one stress challenge that drives clonal
expansions in the Vd2-negative compartment, a recent study
from Ravens et al. and published in Nature Immunology (doi:
10.1038/ni.3686) has highlighted clonotypic gd T cell expansions
following CMV reactivation after allogeneic stem cell
transplantation.
Methods
T cell isolation and culture and activation. Human peripheral blood mono-
nuclear cells (PBMC) were isolated from heparinized venous blood from con-
senting healthy donors (protocol approved by the NRES Committee West
Midlands ethical board; REC reference 14/WM/1254). Brieﬂy, blood was layered
over lymphoprep (Stem Cell Technologies) with resulting PBMC used for sub-
sequent experiments. Plasma was also harvested for CMV IgG (ELISA kit) mea-
surement. For repertoire analysis, all T-cell populations were sorted directly into
RNAlater (Sigma) or RLT buffer (Qiagen) supplemented with b-mercaptoethanol
(Sigma) on a MoFlo Astrios Cell Sorter (Beckman Coulter). For activation and
proliferation of T cells, either PBMC or isolated CD3þ T cells, obtained by positive
magnetic bead isolation (Miltenyi), were labelled or not with 0.3 mM CFSE
(eBioscience) and cultured with cytokines, 25 ngml 1 IL-7 (Peprotech),
100 IUml 1 IL-2, 25 ngml 1 IL-15, 5 ngml 1 IL-12, 5 ngml 1 IL-18
(all Miltenyi), and/or antibodies directed against CD3 (OKT3; eBioscience), CD28
(28.2), mIgG1k (MOPC-21), TCR gd (B1; all Biolegend) or CD3/CD28 T activator
beads (Invitrogen), where indicated and for up to 7 days in RPMI-1640 medium
(Invitrogen) supplemented with 2mM L-glutamine, 1% sodium pyruvate,
50 mgml 1 penicillin/streptomycin (Invitrogen) and 10% fetal calf serum (Sigma).
Antibodies and flow cytometry. For cell sorting, Vd1þ and Vd2þpopulations
were labelled with anti-CD3 (UCHT1; 1:100), TCR ab (IP26; 1:50), TCR Vd1
(TS8.2 or REA173; 1:100) or TCR Vd2 (B6; 1:100) and where indicated CD27
(M-T271; 1:200) and CD45RA (HI100; 1:200). Alternatively, Vd2neg T cell
populations were sorted by labelling with anti-CD3 (UCHT1; 1:100), TCR ab
(IP26; 1:50), TCR gd (IMMU510; 1:200), TCR Vd2 (B6; 1:100), although this
sorting strategy was subject to antibody interference leading to Vd2þ sequences
contaminating TCR repertoire analyses. For phenotypic analysis, freshly isolated,
frozen PBMC or cultured cells were labelled with Zombie Aqua viability dye
(Biolegend), and the cells were then subsequently stained for cell surface antigens
with antibodies directed against CD3 (UCHT1 or HIT3a; 1:100), CD8 (SK1; 1:200),
CD45RA (HI100; 1:200), CD27 (M-T271; 1:200), CCR7 (G043H7; 1:100), CD62L
(DREG-56; 1:100), CD28 (28.2; 1:80), CD161 (HP-3G10; 1:100), CD16 (3G8;
1:100), CD69 (FN50; 1:100), CD25 (2A3; 1:100), CD54 (HA58; 1:100), TCR Vd2
(B6; 1:100), TCR gd (B1; 1:100), TCR ab (IP26; 1:50); all Biolegend. CD127
(IM1980U; 1:20), TCR gd (IMMU510; 1:200) and TCR Vg9 (IMMU360; 1:400);
Beckman Coulter. TCR Vd1 (TS8.2; 1:100); Fisher Scientiﬁc. TCR Vd1 (REA173;
1:100) and TCR Vd2 (123R3; 1:200); Miltenyi. For intracellular staining, after
surface antibody staining cells were ﬁxed in IC Fixation buffer (eBioscience) and
ﬁnally stained in Permeabilisation Buffer (eBioscience) with antibodies directed
against Granzyme A (CBO9; 1:100), Granzyme B (GB11; 1:100) and Perforin
(B-D48; 1:80); all Biolegend. Cells were acquired on an LSR II (Beckton Dickinson)
and data analysed with FlowJo V10.1 (TreeStar).
RNA-based TCR repertoire analysis. RNA was puriﬁed from sorted cells
(cell numbers detailed in Supplementary Table 1 and FACS sorting strategy
identiﬁed in Supplementary Fig. 8) using an RNAmicro kit (Qiagen) according to
the manufacturer’s instructions. For high throughput deep sequencing of TCRs, we
used amplicon rescued multiplex (ARM)-PCR and NGS methods47 to analyse all
sorted gd T cell populations. Following initial ﬁrst-round RT-PCR using high
concentrations of gene-speciﬁc primers universal primers were used for the
exponential phase of ampliﬁcation48 (Patent: WO2009137255A2), allowing deep,
quantitative and non-biased ampliﬁcation of TCR g and TCR d sequences. All
cDNA synthesis, ampliﬁcation, NGS library preparation and sequencing were
performed by iRepertoire, Inc. (Huntsville, USA). We analysed positively sorted
Vd1þ gd T cells from CMV-seronegative (n¼ 10), CMV-seropositive individuals
(n¼ 10), Umbilical Cord blood (n¼ 5; Anthony Nolan Trust, Nottingham),
TCR gdþ Vd2neg T cells (n¼ 4) and Vd2þ T cells (n¼ 4). For low throughput
TCR repertoire sequencing, Vd1þ T cells were sorted into RNAlater using an
ARIA II (BD) ﬂow sorter. cDNA was synthesized using SMARTer RACE cDNA
Ampliﬁcation Kit (Clontech) and TCRg or TCRd sequences were ampliﬁed using a
template-switch anchored RT-PCR with a 30 Cg or Cd speciﬁc primer. Amplicons
were cloned into a TOPO-TA vector (Life Technologies), transformed into
Escherichia coli, and 96 colonies sequenced.
TCR sequence analyses. The CDR3 length was deﬁned as the number of amino
acids between the second Cys of the V region and the Phe of the J region, according
to IMGT. N and P nucleotides were identiﬁed using the IMGT Junction Analysis
tool49,50. Vg9 and Vd2 sequence logos were generated on the Seq2Logo server51 in
Shannon format without the use of pseudocounts, and give a visual representation
of amino acids enriched at different positions in the observed CDR3 sequences.
The different amino acids are coloured according to physicochemical properties
(acidic (DE), red; basic (RKH), blue; hydrophobic (ACFILMPVW), black; and
neutral (NGSGTY), green). For TCRg sequences from Vd2þ cells, the 20 most
prevalent CDR3g of 14aa from each of the four adult donors were included
(80 sequences in total). For TCRd sequences, the ten most abundant clonotypes of
13-15 amino acids using Vd2-Jd1 from each donor were aligned using Clustal
Omega52 with default parameters, before logo generation. Narrower bars in the
sequence logo correspond to gaps in the sequences.
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Single cell PCR analysis of Vd1þ T cells. PBMC were labelled as above and
Vd1þ T cells were single cell sorted directly into individual wells in a 96-well
plate containing 2 ml of Superscript VILO cDNA synthesis kit reaction mix
(ThermoFisher) containing 0.1% Triton X-100, and incubated according to
manufacturer’s instructions. TCRg and TCRd cDNAs were ampliﬁed by two
rounds of nested PCR using GoTaq mastermix (Promega) and following primers:
for Vd1, CAAGCCCAGTCATCAGTATCC (external) and CAACTTCCCAGCA
AAGAGATG (internal); for Cd GCAGGATCAAACTCTGTTATCTTC (external)
and TCCTTCACCAGACAAGCGAC (internal); for Vg1-8 ctggtacctacaccaggagg
ggaagg (external) and TGTGTTGGAATCAGGAVTCAG (internal); for Vg9
AGAGAGACCTGGTGAAGTCATACA (external) and GGTGGATAGGATAC
CTGAAACG (internal) and for Cg CTGACGATACATCTGTGTTCTTTG
(external) and AATCGTGTTGCTCTTCTTTTCTT (internal). PCR products were
separated on 1.2% agarose gels, and products of successful reactions were incubated
with ExoSAP-IT PCR cleanup enzyme (Affymetrix) before sequencing with BigDye
Terminator v3.1 (Applied Biosystems) following manufacturer’s instructions and
cleanup and running on an ABI 3730 capillary sequencer (Functional Genomics
Facility, University of Birmingham).
TCR repertoire data analysis. V, D and J gene usage and CDR3 sequences
were identiﬁed and assigned and tree maps generated using iRweb tools
(iRepertoire, Inc, Huntsville, AL, USA)53. Tree maps show each unique CDR3
as a coloured rectangle, the size of each rectangle corresponds to each CDR3s
abundance within the repertoire and the positioning is determined by the V region
usage. For more detailed analysis and error correction data sets were then
processed using the MiXCR software package54. Diversity metrics, clonotype
overlap and gene usage were plotted in R, by VDJTools55. Data are either presented
as normalized (each unique CDR3 is assigned a count of one, regardless of
frequency), or as non-normalized (which takes into account the frequency of each
unique CDR3).
Statistical analysis. Tabulated data were analysed in Graphpad PRISM 7
(Graphpad Software Inc) and sequencing data by VDJTools55. Each data
set was assessed for normality using Shapiro-Wilko normality tests. Two-tailed
Student’s t-tests were used for normally distributed data and Mann-Whitney for
non-parametric data. Differences between groups were analysed using one-way
ANOVA with Holm-sidak’s post-tests for normally distributed data or with
Kruskal–Wallis ANOVA and Dunn’s post-tests for non-parametric data; two-way
ANOVA was used when comparing groups with independent variables. *Po0.05,
**Po0.01, ***Po0.001 and ****Po0.0001. Correlation was assessed for normally
distributed data with Pearson’s correlation coefﬁcient or Spearman correlation for
non-parametric data.
Data availability. The sequence data that support the ﬁndings of this study have
been deposited in the NIH NCBI sequence read archive (SRA) database with the
primary accession code SRP096009.
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